Healthcare

Lindsay Goldberg to buy Bilcare Research: Reuters

Lindsay Goldberg is buying Bilcare Research, a Swiss pharma packaging company, reported Reuters. The deal puts Bilcare at a valuation between $279 million and $334 million.

On-demand behavioral health firm Ginger nets $35 mln Series C

Ginger, an on-demand behavioral health company, has raised $35 million in Series C funding. WP Global Partners led the round with participation from City Light Capital, Nimble Ventures, LinkedIn CEO Jeff Weiner, Khosla Ventures, Kaiser Permanente Ventures and Kapor Capital.

Scottish medical device company Calcivis snags funding

Calcivis, a Scottish medical device company focused on managing tooth decay and preventive dentistry, has completed 4.5 million pounds in funding. Archangels, an Edinburgh-based business angel investment syndicate, led the round with participation from the Scottish Investment Bank.

Grant Avenue Capital beefs up team with three new hires

New York-based Grant Avenue Capital LLC, a healthcare-focused private equity firm, has hired Alex Ferree and Eric Kim as senior associates. Also, Sari Ring has joined the firm as chief of staff. Previously, Ferree worked at Audax Private Equity where he was an associate while Kim was an associate at Morgan Stanley Capital Partners. And, prior to joining Grant Avenue Capital, Ring worked for two nonprofits, the Alzheimer's Association and Best Buddies.

Vensana wraps up inaugural medtech fund

Vensana Capital, which was launched by healthcare-focused venture firm Versant Ventures, has closed its debut fund at US$225 million. Vensana Capital I's limited partners include public pensions, university endowments, foundations, academic health systems, family offices and fund-of-funds. The fund will invest in the medical tech sector. Versant's offices include San Diego, San Francisco, Minneapolis, New York City and Vancouver, British Columbia.

Achilles Therapeutics lands Series B funding

UK-based Achilles Therapeutics, a biopharmaceutical company, has secured 100 million pounds in Series B funding. RA Capital Management led the round. Goodwin's London life sciences practice advised Achilles on the fundraising.

Great Hill recaps Pareto Health

Great Hill Partners has completed a recap of Pareto Health Inc. Financial terms weren’t announced. Pareto is an employee benefit group captive manager that helps businesses with more than 50 employees self-fund health benefits.

PE-backed Advancing Eyecare acquires Ophthalmic Instruments

Advancing Eyecare, which is backed by Atlantic Street Capital, has acquired Ophthalmic Instruments Inc, a distributor of ophthalmic instruments. No financial terms were disclosed.

Vertex to buy VC-backed Semma for $950 mln

Vertex Pharmaceuticals Incorporated has agreed to acquire Cambridge, Massachusetts-based Semma Therapeutics, a biotech company focused on treating type 1 diabetes, for $950 million in cash. Semma's backers include Eight Roads Ventures, Cowen Healthcare Investments, MPM Capital, F-Prime Capital Partners, ARCH Venture Partners, Novartis, Medtronic, JDRF T1D Fund, ORI Healthcare Fund, Wu Capital, 6 Dimensions Capital and SinoPharm Capital.

Shore-backed EyeSouth Partners invests in Louisiana eyecare practices

EyeSouth Partners, a portfolio company of Shore Capital Partners, has invested in Eyecare Associates, Outpatient Eye Surgery Center, Eye Laser Institute, The Looking Glass as well as Scott D. Lanoux MD & Associates and L&L Optical. Financial terms weren’t announced. The practices, which provide eye care services, employ about 100 support staff in Louisiana.